Until a few years ago, only the tech world had companies valued at $1 billion. Therefore, the nickname “Unicorn” refers to the scarce area occupied by these companies. Healthcare unicorns are rare.
With the current bubble-like valuation, unicorns are now a dime even in the healthcare sector, although it is not entirely clear whether they have substantial revenue or profit.The latest addition to this billion-dollar club is Iodine Software, It uses artificial intelligence to correctly record the clinical interventions and services that hospitals provide to patients so that they can accurately code and bill, and get paid for these services. Iodine Software, founded in 2010, is clearly profitable, although like many companies, its financial details are in the hands of executives.
The company announced on Wednesday that private equity firms Arrival International Holding a “significant share” in a transaction that made the company a unicorn. No other financial details were disclosed. After Advent’s investment, Bain Capital and another private equity firm, Silversmith Capital Partners, remain shareholders.
William Chan, CEO of Iodine, said: “This investment provides funding channels for expansion and growth strategies so that we can innovate faster and find more ways to enhance the capabilities of healthcare leaders to achieve quality, The delicate balance between efficiency and the financial flexibility of the system.” and co-founder, in a press release.
Later, in an email replying to the question forwarded by the spokesperson, Chan explained that the correct recording of the clinical services provided is a difficult task, which is mainly a manual process and requires the clinical expertise of doctors and nurses. Clinical Document Integrity (CDI) and utilization management team cooperates with doctors and nurses to ensure that the entire patient’s journey and experience in the hospital are recorded correctly from a clinical perspective. If this is not the case, the hospital will suffer heavy losses in the so-called mid-term income in the industry (income from treating and caring for patients in the hospital).
“Most of the mid-term cycle is filled with complex tasks, requiring professional CDI and UM nurses to make clinical judgments to ensure that the documentation is completely complete,” Chan said. “Before iodine, these tasks were difficult to automate because they required clinical judgment to complete.”
He said that Iodine’s AI-driven CognitiveML engine is now capable of clinical evaluation because a large amount of clinical data has been input to train algorithms from many different clinical records. He added that these assessments are based on models trained on 29 million hospitalizations, 3.3 billion individual clinical observations (for example, laboratory results, vital signs), and more than 1.5 billion medical concepts and other information.
“As a result, these assessments allow us to automate tasks that usually require human clinical judgment to complete,” he said. “These assessments also allow us to predict various details about the patient’s length of stay, such as the approximate length of time the patient will stay in the hospital and the possible final coded diagnosis after discharge.”
The above content seems to have convinced hospital managers to adopt Iodine’s products-the company claims to have more than 800 medical system customers in the United States, including Advent Health, HCA, Tenet Healthcare, Mount Sinai Health System, Baylor Scott & White, etc. Chan said that the company is currently profitable and its revenue has increased by 40% from 2020 to 2021, but declined to provide more specific information.
The combination of a solid customer base and strong revenue growth, like music to any investor, may have played a role in prompting Advent International to invest in the company.
Carmine Petrone, managing director of Advent’s medical team, said in a press release: “Iodine’s world-class AI innovation engine and strong customer focus support the company’s ability to provide first-class products with highly differentiated values.”
Chen said that iodine helped the hospital generate an additional $1 billion in revenue per year across its entire customer base. Considering how the pandemic has damaged the financial situation of the hospital, this must arouse the interest of any hospital administrator.Before the pandemic, the hospital’s financial situation was already very difficult, now it’s worse News of bankruptcy and bankruptcyTherefore, any technology that can effectively prevent any form of income loss will be like nectar from heaven.
Not surprisingly, the CDI market is Expected to reach According to market research firm Markets and Markets, it will reach US$4.5 billion by 2023, up from US$3.1 billion in 2018. The report found that the market’s “growth is largely due to the increasing use of mid-term revenue cycle management solutions to reduce medical costs, check for revenue losses due to medical billing and coding errors, and address the decline in reimbursement rates. Issues, manage the ever-increasing amount of unstructured data, and maintain compliance.”
Nevertheless, iodine still has its competitors in the field of artificial intelligence-driven clinical document integrity.When asked about the game, Chen replied 3M, And Nuance, this is Acquired by Microsoft earlier this year, both play a role in the field [Author of this article owns Nuance shares]The two companies specialize in using artificial intelligence to help CDI. But there are other outstanding players. According to market and market reports, they are Optum, M*Modal, nThrive, Dolbey Systems, Streamline Health, Vitalware, Craneware, Epic Systems, Cerner, eZDI Inc., Flash Code and TruCode.
Although hospitals have been slow to adopt digital tools, the pandemic has changed the dynamics meaningfully. This is the opportunity.
Yumin Choi, partner of Bain Capital Ventures, said: “We see the huge potential that its artificial intelligence software will provide for hospitals undergoing digital transformation. “Through this strategic investment, Iodine will have the opportunity to reach more hospitals. Professionals to provide better care for patients across the United States”
Photo: adventtr, Getty Images
